Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease

Bruna Damásio Moutinho; Jaqueline Ribeiro de Barros; Julio Pinheiro Baima; Rogerio Saad-Hossne; Ligia Yukie Sassaki

doi:10.12659/AJCR.920949

27 March 2020 : Case report Brazil

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease

Adverse events of drug therapy, Clinical situation which can not be reproduced for ethical reasons

Bruna Damásio Moutinho^1ABCDEF, Jaqueline Ribeiro de Barros^1ABCDEF, Julio Pinheiro Baima^1ABCDEF, Rogerio Saad-Hossne^2ABCDEF, Ligia Yukie Sassaki^1ABCDEF*

DOI: 10.12659/AJCR.920949

Am J Case Rep 2020; 21:e920949

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

Export

Export Article Citation

Share via email

Share method:

Via email client program

Send me to my email

Content:

Title, authors, link

Title, authors, link, abstract

Immunosuppression and Malignant Neoplasms: Risk-Benefit Assessment in Patients with Inflammatory Bowel Disease

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy